Stay updated with breaking news from Pascal Touchon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) was the recipient of a significant decrease in short interest in May. As of May 15th, there was short interest totalling 14,180,000 shares, a decrease of 20.3% from the April 30th total of 17,790,000 shares. Based on an average daily trading volume, of 1,420,000 shares, the short-interest ratio […]
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) saw a large decrease in short interest in May. As of May 15th, there was short interest totalling 14,180,000 shares, a decrease of 20.3% from the April 30th total of 17,790,000 shares. Based on an average daily volume of 1,420,000 shares, the days-to-cover ratio is currently 10.0 days. […]
M28 Capital Management LP purchased a new position in shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 439,300 shares of the biotechnology company’s stock, valued at approximately $1,441,000. Atara Biotherapeutics makes […]
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) has been given a consensus rating of “Hold” by the nine analysts that are covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. The average […]
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) has earned a consensus recommendation of “Hold” from the nine research firms that are covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating on the company. The […]